Search results
Results from the WOW.Com Content Network
The U.S. Food and Drug Administration in 2020 pulled all brands named Zantac and generic versions of the drug off the market, triggering a wave of lawsuits. The drug, approved over four decades ...
The drugmaker has settled a series of lawsuits related to Zantac over the past 12 months, including several in California. California is generally seen as a more challenging legal environment for ...
Mayo v. Prometheus, 566 U.S. 66 (2012), was a case decided by the Supreme Court of the United States that unanimously held that claims directed to a method of giving a drug to a patient, measuring metabolites of that drug, and with a known threshold for efficacy in mind, deciding whether to increase or decrease the dosage of the drug, were not patent-eligible subject matter.
SACRAMENTO, Calif. (AP) — California on Thursday announced it will sue the companies that make and promote most of the The post California latest to sue drug companies over insulin prices ...
The Consumer Attorneys Association of Los Angeles (CAALA), previously the Los Angeles Trial Lawyers Association (LATLA), is one of the largest associations of plaintiffs lawyers in the United States. [ 1 ] [ 2 ] Although CAALA refers to itself as a local association, it has almost 3,000 members and is larger than all but six state trial-bar ...
Sitagliptin, sold under the brand name Januvia among others, is an anti-diabetic medication used to treat type 2 diabetes. [8] In the United Kingdom it is listed as less preferred than metformin or a sulfonylurea. [9] It is taken by mouth. [8] It is also available in the fixed-dose combination medication sitagliptin/metformin (Janumet, Janumet ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease. Whose cardiovascular health do SGLT2, GLP-1 diabetes ...
By 2010 the company was based in Menlo Park, California, and stated it intended to become profitable in 2011. [13] By 2010, Depomed was supplying its entire logistics system with plastic pallets, after it had to recall a shipment of the diabetes drug Glumetza for potential contamination of wood pallets. [14]